RA Capital Management, L.P. 13D and 13G filings for Concert Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
RA Capital Management, L.P. | 5,199,746 9.990% |
1,689,643 (+48.14%) |
Filing |
| 2022-02-14 4:11 pm Purchase |
2021-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
RA Capital Management, L.P. | 3,510,103 9.990% |
1,686,583 (+92.49%) |
Filing |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
RA Capital Management, L.P. | 1,823,520 5.900% |
1,823,520 (New Position) |
Filing |